Nuclear Medicine: Page 109

Navidea to sublicense PET imaging agent

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has proposed a nonbinding sublicensing agreement with Cerveau Technologies for the development and marketing of NAV4694, a beta-amyloid imaging agent being evaluated for the diagnosis of Alzheimer's disease using PET.

August 8, 2016

IBA cyclotron opens ahead of schedule

By AuntMinnie.com staff writers

Proton therapy and radiopharmacy vendor Ion Beam Applications (IBA) said that it and Zevacor Molecular have completed acceptance testing for a Cyclone 70 cyclotron installed at Zevacor's Noblesville, IN, facility.

August 4, 2016

Australian project to boost world Mo-99 supply

By AuntMinnie.com staff writers

Australia is promising to significantly boost the world's perennially short molybdenum-99 (Mo-99) supply with completion of several hot cells that will come online this year just as other large producers are shutting down.

August 4, 2016

Lantheus notches strong Q2 results

By AuntMinnie.com staff writers

Continued strong sales of its Definity ultrasound contrast agent and stable revenues from nuclear products powered growth for Lantheus Medical Imaging's parent company, Lantheus Holdings, in its second quarter.

August 4, 2016

PET/CT calcium scores reveal chemo's damage to the heart

By Wayne Forrest

By comparing baseline and follow-up coronary calcium scores from PET/CT scans of lymphoma patients after chemotherapy, researchers say they can better follow the cancer treatment's debilitating impact on the heart, and perhaps get a better handle on possible cardiotoxicity.

August 3, 2016

Mallinckrodt sees nuclear imaging revenues drop in Q3

By AuntMinnie.com staff writers

Pharmaceutical developer Mallinckrodt's Nuclear Imaging business segment produced lower revenues in its 2016 fiscal third quarter.

August 1, 2016

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

July 31, 2016

Is MBI a better alternative for dense breast screening?

By Kate Madden Yee

Almost half of women eligible for breast cancer screening have dense tissue -- a characteristic that can limit conventional mammography's performance. To work around this, clinicians need supplemental imaging modalities, and molecular breast imaging (MBI) is an effective option, according to a study published in the August issue of the American Journal of Roentgenology.

July 31, 2016

Zecotek reports PET milestone in China

By AuntMinnie.com staff writers

Photonic technologies developer Zecotek Photonics said a major manufacturer in China has assembled its first high-resolution PET scanner for testing using Zecotek scintillation crystals.

July 28, 2016

Digirad doubles Q2 revenues thanks to DMS purchase

By AuntMinnie.com staff writers

Nuclear medicine firm Digirad saw revenues for the company's second quarter more than double thanks to contributions from its acquisition of DMS Health.

July 28, 2016

Nuclear medicine training helps radiologists

By Wayne Forrest

Radiologists who receive training in nuclear medicine are still able to interpret anatomical imaging studies just as well as general radiologists, according to a new study. The research is good news for efforts to create a unified training program for hybrid imaging.

July 26, 2016

PET with tau agent sheds light on Alzheimer's disease

By Wayne Forrest

PET imaging of tau proteins with a novel radiotracer based on fluorine-18 is showing great promise in differentiating between Alzheimer's patients and cognitively normal individuals and identifying how the disease may develop, according to a study published online July 25 in JAMA Neurology.

July 24, 2016

Previous Page

Page 109 of 440

Next Page